These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22406696)

  • 21. The past and future of neuroprotection in cerebral ischaemic stroke.
    Shuaib A; Hussain MS
    Eur Neurol; 2008; 59(1-2):4-14. PubMed ID: 17917451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition.
    Jung KH; Chu K; Lee ST; Park HK; Kim JH; Kang KM; Kim M; Lee SK; Roh JK
    Biochem Biophys Res Commun; 2009 Jan; 378(3):507-12. PubMed ID: 19056343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention.
    Broussalis E; Killer M; McCoy M; Harrer A; Trinka E; Kraus J
    Drug Discov Today; 2012 Apr; 17(7-8):296-309. PubMed ID: 22134007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuroprotection in brain ischemia--doubts and hopes].
    Zádor Z; Benyó Z; Lacza Z; Hortobágyi T; Harkány T; Hortobágyi T
    Ideggyogy Sz; 2004 Mar; 57(3-4):81-93. PubMed ID: 15133909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
    Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy of cerebral ischemia.
    Ducruet AF; Grobelny BT; Zacharia BE; Hickman ZL; Yeh ML; Connolly ES
    Expert Opin Pharmacother; 2009 Aug; 10(12):1895-906. PubMed ID: 19514865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic neuroprotective effects of XQ-1H in a rat model of permanent focal cerebral ischemia.
    Yang Q; Fang W; Lv P; Geng X; Li Y; Sha L
    Pharmacology; 2012; 89(1-2):1-6. PubMed ID: 22178991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targets of cytoprotection in acute ischemic stroke: present and future.
    Lizasoain I; Cárdenas A; Hurtado O; Romera C; Mallolas J; Lorenzo P; Castillo J; Moro MA
    Cerebrovasc Dis; 2006; 21 Suppl 2():1-8. PubMed ID: 16651809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
    Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
    Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental studies on ischemic neuroprotection: criteria for translational significance.
    Bhardwaj A
    Crit Care Med; 2011 May; 39(5):1230-1. PubMed ID: 21610593
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats.
    Chauhan A; Sharma U; Jagannathan NR; Reeta KH; Gupta YK
    Behav Brain Res; 2011 Dec; 225(2):603-9. PubMed ID: 21903138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
    Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.
    Sevimli S; Diederich K; Strecker JK; Schilling M; Klocke R; Nikol S; Kirsch F; Schneider A; Schäbitz WR
    Exp Neurol; 2009 Jun; 217(2):328-35. PubMed ID: 19332060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrovascular endothelin receptor upregulation in cerebral ischemia.
    Edvinsson L
    Curr Vasc Pharmacol; 2009 Jan; 7(1):26-33. PubMed ID: 19149637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of neuroprotective agents in the treatment of acute ischemic stroke.
    Lutsep HL; Clark WM
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):13-8. PubMed ID: 11898495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714.
    Pozo-Rodrigálvarez A; Gradillas A; Serrano J; Fernández AP; Martínez-Murillo R; Pérez-Castells J
    Eur J Med Chem; 2012 Aug; 54():439-46. PubMed ID: 22703704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M; Benatar M; Fisher M; Savitz SI
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DJ-1 based peptide, ND-13, promote functional recovery in mouse model of focal ischemic injury.
    Molcho L; Ben-Zur T; Barhum Y; Offen D
    PLoS One; 2018; 13(2):e0192954. PubMed ID: 29489843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.